SBC vs. TDOC, AUNA, AIRS, LFMD, SHLT, TOI, CCM, HIMS, HRMY, and MIRM
Should you be buying SBC Medical Group stock or one of its competitors? The main competitors of SBC Medical Group include Teladoc Health (TDOC), Auna (AUNA), AirSculpt Technologies (AIRS), LifeMD (LFMD), SHL Telemedicine (SHLT), Oncology Institute (TOI), Concord Medical Services (CCM), Hims & Hers Health (HIMS), Harmony Biosciences (HRMY), and Mirum Pharmaceuticals (MIRM).
SBC Medical Group vs.
SBC Medical Group (NASDAQ:SBC) and Teladoc Health (NYSE:TDOC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.
In the previous week, SBC Medical Group had 1 more articles in the media than Teladoc Health. MarketBeat recorded 4 mentions for SBC Medical Group and 3 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.63 beat SBC Medical Group's score of 0.23 indicating that Teladoc Health is being referred to more favorably in the news media.
Teladoc Health received 678 more outperform votes than SBC Medical Group when rated by MarketBeat users.
SBC Medical Group has higher earnings, but lower revenue than Teladoc Health.
SBC Medical Group has a net margin of 0.00% compared to Teladoc Health's net margin of -37.91%. Teladoc Health's return on equity of -10.06% beat SBC Medical Group's return on equity.
SBC Medical Group has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.
60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 63.9% of SBC Medical Group shares are owned by company insiders. Comparatively, 1.0% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Teladoc Health has a consensus price target of $12.24, suggesting a potential upside of 28.84%. Given Teladoc Health's stronger consensus rating and higher probable upside, analysts clearly believe Teladoc Health is more favorable than SBC Medical Group.
Summary
Teladoc Health beats SBC Medical Group on 10 of the 14 factors compared between the two stocks.
Get SBC Medical Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SBC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SBC Medical Group Competitors List
Related Companies and Tools
This page (NASDAQ:SBC) was last updated on 1/22/2025 by MarketBeat.com Staff
Free SBC Stock Alerts